TEMPORAL · TEMPORAL IMG: Temporal radiation imager for nuclear equipment dismantling and nuclear medicine

Damavan imaging is developing a breakthrough innovation in gamma ray imaging: Temporal imaging. This innovation can be used for various applications, mostly in medical imaging. The most advanced application in term of development (TRL6) is a Portable Compton Camera for nuclear decommissioning, subject of this proposal. We absolutely need this launch market, but most of our long term value potential is in medical imaging.Our innovation is based on using both spatial and time distribution of photons in monolithic and fast scintillators. It allows better localization of gamma photons in space, time and energy. This innovation is protected by 7 patents claims so far and has been presented in international conferences.Our technology brings better angular resolution, sensitivity and reduced cost to Compton camera. We are currently testing our prototype in the field and have obtained first orders from major actors.The “binocular” Compton camera evolution we are proposing here, will produce a 3D Map of radioactivity in one image allowing cost reduction and a safety improvement for operators in nuclear decommissioning operations. The market for this type of imagers today is 20 M$ but growing quickly (>20%/ year). Our approach is to partner with companies in nuclear instrumentation to overcome heavy barriers to entry in the field, selling them a nearly finished product. Temporal imaging is a generic solution: the biggest existing potential is PET scanners (1,5 G$ +7%/year growth). But developing this business will take 5 years! We have identified new potential markets for our Compton camera where no credible imaging solution exists. We believe we can make strong margin there, with easier entry than in PET but we need a market study to be sure.World is our playground, Europe is our base: more than 80% of our sales are and will be abroad.By being selected for this call we would get critical market information and enhance our credibility for fundraising in Europe.